222 related articles for article (PubMed ID: 35884177)
1. Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.
Ahmed H; Bergmann F; Zeitlinger M
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884177
[TBL] [Abstract][Full Text] [Related]
2. An update on the importance of plasma protein binding in drug discovery and development.
Di L
Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
[No Abstract] [Full Text] [Related]
3. Interspecies variability in protein binding of antibiotics basis for translational PK/PD studies-a case study using cefazolin.
Ahmed H; Böhmdorfer M; Eberl S; Jäger W; Zeitlinger M
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0164723. PubMed ID: 38376186
[TBL] [Abstract][Full Text] [Related]
4. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
[TBL] [Abstract][Full Text] [Related]
5. Protein binding in antiretroviral therapies.
Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
[TBL] [Abstract][Full Text] [Related]
6. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
Pacifici GM; Viani A
Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
[TBL] [Abstract][Full Text] [Related]
7. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
[TBL] [Abstract][Full Text] [Related]
8. Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
Acharya MR; Sparreboom A; Sausville EA; Conley BA; Doroshow JH; Venitz J; Figg WD
Cancer Chemother Pharmacol; 2006 Feb; 57(3):275-81. PubMed ID: 16028097
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic investigations into the species differences in pinometostat clearance: impact of binding to alpha-1-acid glycoprotein and permeability-limited hepatic uptake.
Smith SA; Gagnon S; Waters NJ
Xenobiotica; 2017 Mar; 47(3):185-193. PubMed ID: 27160567
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.
Smith SA; Waters NJ
Pharm Res; 2018 Dec; 36(2):30. PubMed ID: 30593605
[TBL] [Abstract][Full Text] [Related]
11. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
[TBL] [Abstract][Full Text] [Related]
13. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
Weiss HM; Gatlik E
J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
[TBL] [Abstract][Full Text] [Related]
14. Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs.
Pike A; Jones B; Markandu R; O'Neill D
Drug Metab Dispos; 2021 Sep; 49(9):736-742. PubMed ID: 34135088
[TBL] [Abstract][Full Text] [Related]
15. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
Klotz U; Antonin KH; Bieck PR
J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
[TBL] [Abstract][Full Text] [Related]
17. Impact of pH on plasma protein binding in equilibrium dialysis.
Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
[TBL] [Abstract][Full Text] [Related]
18. Assaying protein unbound drugs using microdialysis techniques.
Tsai TH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 797(1-2):161-73. PubMed ID: 14630148
[TBL] [Abstract][Full Text] [Related]
19. Plasma protein binding: from discovery to development.
Bohnert T; Gan LS
J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
[TBL] [Abstract][Full Text] [Related]
20. Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins.
Richter WF; Heizmann P; Meyer J; Starke V; Lave T
J Pharm Sci; 1998 Apr; 87(4):496-500. PubMed ID: 9548904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
